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The  MRL/Mp-lpr/lpr  (MRL/1)  mouse  develops  a  T  cell  lymphoproliferative 
syndrome  associated with  a  systemic lupus  erythematosus  (SLE)Llike disorder  (1). 
The disease is marked by massive lymph node enlargement, hypergammaglobuline- 
mia, and  production of multiple autoantibodies that  include anti-DNA, anti-gp70, 
and rheumatoid factors (2). 
The proliferating cells of MRL/1  mice are of the Thy-1 +, Lyt-1 + phenotype  (2-4). 
The thymus dependency of these cells is substantiated by the finding that  neonatal 
thymectomy  abrogates both  the  lymphoproliferation and  autoimmune  disorder  (5, 
6).  The  disease complex  of MRL/1  mice  can  be  attributed  to  a  single  autosomal 
recessive gene locus, named lpr (1). Thus,  mice of the congenic strain MRL/Mp-+/ 
+  (MRL/n),  which lack the lpr gene but share >98%  of their genome with MRL/1 
mice,  do  not  develop  lymphoproliferation  and  develop  autoimmunity  late  in  life 
(1, 2). 
Previous studies revealed that MRL/I  T  cells provide increased antigen-nonspecific 
help to B  cells (7)  and promote anti-DNA antibody production  (8). This increase in 
helper activity occurs despite MRL/1 T  cells' markedly lower production of interleukin 
2  (IL-2)  (9-11). 
In  this  paper  we  document  the  production  of a  B  cell  differentiation  factor(s) 
(BCDF) in vitro by MRL/1 T  cells in the absence of mitogenic stimulation. The factor 
is not produced by lymphoid cells from the non-lpr-bearing congenic MRL/n  strain 
or from several immunologically normal murine strains. A BCDF is also spontaneously 
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produced by T  cells of the autoimmune C57BL/6J-lpr/lpr  (B6/1)  strain.  Although T 
cells  synthesize  a  variety  of lymphokines  in  response  to  T  cell  mitogens  or  to  T- 
dependent  antigens,  in  mixed  lymphocyte  culture  or  when  cloned  (12),  to  our 
knowledge this represents  the first example of a  T  helper factor produced spontane- 
ously by unstimulated  and uncloned T  cells. 
In  view  of its  origin  from  mice  of the  lpr/lpr  genotype,  we  term  this  B  cell 
differentiation  factor(s)  L-BCDF.  L-BCDF increases  immunoglobulin  (Ig)  secretion 
in unstimulated  B cells; however, it has a  much greater effect on anti-/z- or lipopoly- 
saccharide  (LPS)-activated  B  cells.  Our experiments  do not  establish  whether  only 
one  factor is  present  that  acts  on  both  stimulated  and  unstimulated  B  cells.  This 
question  is  difficult  to resolve  because  even  "unstimulated"  B  cells  may contain  a 
small  percentage of B  cells activated  in  vivo or in culture  (e.g.,  by fetal  calf serum 
[FCS]). L-BCDF induces both IgM and IgG production and, interestingly, acts in the 
absence of either  IL-2 or B  cell  growth  factor  (BCGF).  Moreover,  L-BCDF has  no 
conventional T  cell replacing factor (TRF) activity. Our results point to an association 
of the lpr gene with T  cell proliferation,  production of a  BCDF, and autoimmunity. 
Materials and Methods 
Mice.  C3H/St  (H-2k),  C57BL/6 (H-2b), and BALB/c (H-2  d) are bred and maintained in 
our colony. MRL/1  (H-2  k) and MRL/n  (H-2  k) were developed by Dr. E.  M. Murphy and 
originally  obtained  from  The Jackson  Laboratory,  Bar  Harbor,  ME,  but  were  bred  and 
maintained thereafter in our colony. C57BL/6J-lpr/lpr (B6/I) mice were kindly given to us by 
Dr. D. Johnson (Scripps Clinic and Research Foundation, La Jolla, CA) and also originated 
from The Jackson Laboratory. Mice used in these experiments were 6- to  18-wk-old  females, 
unless  otherwise indicated. 
Preparation of T Cell- and Macrophage-depleted Populations and Culture Conditions.  To deplete T 
cells, spleen cell suspensions were treated with monoclonal anti-Thy-1.2 (NEI-001; New England 
Nuclear, Boston, MA) and guinea pig complement (C). This treatment completely abrogated 
the response to concanavalin A (Con A). Such T cell-depleted populations contained between 
5 and  10% macrophages as determined  by nonspecific esterase  staining  (13) or by indirect 
immunofluorescence with a monoclonal rat anti-mouse macrophage antibody (M 1/70HL, lot 
E22800; Hybritech Inc., La Jolla, CA) (14). In a few experiments (see Results), such contami- 
nating  macrophages  were  removed  by  passage  of the  T  cell:depleted  populations  over  a 
Sephadex G-10 column as described (15). After such passage, the effluent cells contained <1% 
positive cells by nonspecific esterase and <0.3% by the monoclonal anti-Mac antibody. 
For assaying responses  to supernatants  from splenic  or lymph node cell  cultures,  B cells 
(2 ×  105-2 ×  10  ° cells/ml)  were incubated in 96-well,  flat-bottomed microtiter plates  (3072; 
Falcon Labware,  Becton Dickinson  & Co., Oxnard,  CA). Medium consisted of RPMI  1640 
supplemented with 25 mH Hepes (M. A. Bioproduets, Walkersville, MD), 50/zM 2-mercapto- 
ethanol, a mixture of penicillin  (50 U/ml) and streptomycin (50 #g/ml)  (M. A. Bioproducts), 
and  10% FCS (lot  29101276;  Flow Laboratories, Inc., Rockville, MD). Cells were cultured in 
the presence of 7% CO2 at 37°C. 
In some experiments, B cells were activated with LPS or with Sepharose-bound anti-/1. LPS 
R595 derived from Salmonella minnesota (Calbiochem-Behring Corp., San Diego, CA) was used 
at a concentration of 2.5 ffg/ml. 
Anti-mouse-/t antibody was a goat antibody prepared by hyperimmunization with MOPC- 
104E  (#, ~). This antiserum  was affinity-purified on Sepharose 4B mouse TEPC-183 (/~, g) 
columns and rendered specific by absorption to mouse IgG-Sepharose 4B columns. This anti- 
/~  antibody was  then  conjugated  to cyanogen bromide-activated  Sepharose  4B  beads  at  a 
concentration of 1 mg/ml of Sepharose. Conjugated beads were stored at 4°C in phosphate- 
buffered saline (PBS)  containing 0.02% sodium azide. Before use, the beads were washed five 
times  with  sterile  PBS  and  once  with  medium.  They  were  then  added  in  culture  at  a 
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Proliferative responses  of B cells to anti-/z were assayed on day 3 of culture, after an 18-h 
incubation with 1 #Ci [aH]thymidine/well, 
Plaque-forming Cell Assay.  Ig-secreting cells  (IgSC)  were assayed with a  reverse  hemolytic 
plaque assay  as previously described (7). In all cases plaques were assayed after culturing B 
cells for 4 d. 
Production of Supernatants.  All supernatants derived from spleen or lymph node cells were 
produced under the same conditions. Cells from four or five mice were pooled and cultured at 
a density of 2 ×  106 cells/cm  2 per 0.62 ml of medium for 24 h. The medium used was the same 
as described above for B cell assays. Supernatants recovered were spun at  15,000 rpm for  15 
min, passed  through a 0.45-/zm filter (Acrodisc;  Gelman Sciences,  Inc., Ann Arbor, MI), and 
stored at -70°C for a maximum of 60 d before use. 
Con A  supernatant (CAS)  was  produced  under identical culture conditions except  that 
spleen cells were incubated for 2 h with 4/Lg/ml Con A (Miles Laboratories, Inc., Elkhart, IN) 
at 37°C, washed three times with minimal essential medium, and then cultured in medium for 
24 h. All CAS used in this study were derived from C57BL/6 female mice (6-10 wk old). 
In some experiments, MRL/I spleen cells were depleted of various cell populations before 
incubation to  produce supernatants. In this case,  MRL/1 T  cell-depleted spleen cells  were 
prepared by treatment with a combination of monoclonal anti-Thy-1.2, anti-Lyt-1.2, and anti- 
Lyt-2.1  (all  from New England Nuclear) and guinea pig C.  Selective ablations of Lyt-1 + or 
Lyt-2  +  populations were  performed  by  using anti-Lyt-l.2 and  C,  or  anti-Lyt-2.1  and  C, 
respectively.  To  deplete  B  cells  and  adherent  cells,  petri  dishes  were  coated  with  F(ab')2 
fragments of rabbit anti-mouse Ig (N. L. Cappel Laboratories Inc., Cochranville, PA) according 
to the technique of Wysocki and Sato  (16). Spleen cells were incubated on these plates at a 
concentration of 10  7 cells/plate for 90 min. Recovered unbound cells consisted of >95% T cells 
as  determined  by  immunofluorescence. Dennert  line  TRF  (DL-TRF)  derived  from  line 
C.C3.11.75,  was a kind gift from Dr. G. Dennert, The Salk Institute, La Jolla, CA. 
Radioimmunoassays.  Solid-phase radioimmunoassays  were used to measure IgM, IgG 1, IgG2a, 
IgG2b, and IgG3. The IgM assay  has been described  (17). Briefly,  polystyrene plates were 
coated with goat anti-mouse/~ chain-specific antibody, after which various dilutions of each 
sample were added to the wells. Bound IgM was detected with 1~SI-goat  anti-mouse/z antibody. 
The IgG isotype-specific  radioimmunoassays were direct binding assays.  Plates were incu- 
bated with  100% supernatant, followed  by addition of one of the following isotype specific 
rabbit antibodies purchased from Litton Bionetics Inc., Kensington, MD (catalogue numbers 
are in parentheses): anti-mouse IgG1  (8403-03), anti-IgG2a (8403-04), anti-IgG2b (8403-06), or 
anti-IgG3 (8403-07).  The  assay  was  then developed with  125I-labeled goat  anti-rabbit IgG. 
Specific  absorptions were  performed  to  reduce  the  cross-reactivity of the  antibodies, and 
standard curves were established for each assay by coating the plates with graded amounts of 
mouse myeloma proteins of each isotype,  also purchased from Litton Bionetics Inc. 
IL-2 Assay and Absorption.  The IL-2 assay was performed as described by Gillis et al.  (18), 
using thelL-2-dependent cell line CTLL-2-15-H, which was a gift from Dr. M. Bevan (Scripps 
Clinic and Research Foundation). IL-2 was absorbed with 4 ×  l05 cells of line CTLL-2-15-H 
per milliliter  ofsupernatant by incubation  at 37°C for 24 h. This treatment completely removed 
IL-2 activity from CAS. 
TRFAssay.  5 ×  105 splenic B cells (BALB/c mice) were cultured in 96-well microtiter plates 
with 106 sheep erythrocytes (SRBC) in medium containing 10% FCS (as described above) and 
in the presence or absence of MRL/1-SN or CAS. Direct anti-SRBC plaques were assayed 4 d 
later. 
Results 
Production of a BCDF by Unstimulated MRL/l Lymphoid Cells.  Cells obtained from the 
spleens and lymph nodes of 4-mo-old MRL/1 mice were cultured without stimulation 
for  24  h.  Supernatants  obtained  from  these  cultures  stimulated  Ig  secretion  by 
unmanipulated  (no  mitogens  added)  B  cells  of  several  mouse  strains  (Fig.  1). 
MRL/1-derived  supernatants  (MRL/I-SN)  were  equally effective  on  B  cells  from 
mice  of  the  H-2 b,  H-2 d,  or  H-2 k  haplotypes.  However,  control  MRL/n-derived 70" 
60- 
5O- 
40- 
30- 
20- 
10- 
PRUD'HOMME  ET  AL. 
B ceil  origin 
///-~  -  ~MRL/I 
//  ~  _  .  ..o .....  .,MRLII  + 
*'-"--~~~  ~ ~_~_-_~  ---~  4[i6  MRLIn-SN 
.... 
733 
1'o 
Concentration  of Supernatant 
Fro.  1.  Effect of MRL/I  (  )  or MRL/n  (---)  lymph node cell-derived supernatants on Ig 
secretion by splenic B cells of syngeneic and altogeneic mice. Increasing concentrations (vol/vol) of 
supernatants were added to splenic B cell cultures (5 ×  10  5 cells/well). IgSC were determined at 
day 4 of culture. The results represent the mean of three experiments, t  SD did not exceed 10% of 
the mean for any given point, 
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FIG.  2.  Effect of MRL/I  (  )  and MRL/n  (- - -)  lymph node cell-derived supernatants on Ig 
secretion by splenic B cells of several strains activated with anti-,a antibodies. 5  ×  10  5 B cells were 
incubated with Sepharose-bound anti-/~ (2.5/~g/well) together with lymph node supernatants. IgSC 
were enumerated at day 4 of culture. The results represent the mean of three experiments. 1 SD did 
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Ftc.  3.  Comparison of MRL/I-SN, CAS from normal mice (C57BL/6),  and TRF on ability to 
enhance anti-/t- or LPS-induced Ig secretion. 5 ×  10  s B cells with anti-/t (2.5/tg/well) or LPS  (2.5 
/tg/ml) were cultured with optimal concentrations of MRL/1-SN, CAS, or supernatant from the 
TRF-producing line C.C3.11.75.  IgSC were enumerated after 4 d of culture ±  SD. In the absence 
of LPS or anti-/t the following counts were obtained: untreated B ceils,  10 +  2; MRL/1-SN, 68 ±  4; 
CAS, 35 -  3; C.C3.11.75,  not determined. 
TABLE  I 
Comparison of lg-inducing Ability by Lymphoid Cell-derived Supernatants from Various Mouse Strains 
Strain of origin of supernatants 
Cellular derivation of 
supernatant*  BALB/c  C57BL/6  C3H  MRL/n  MRL/I~  C57BL/ 
6-15 
Spleen cells  <15§  <15  <15  <15  683  _+ 45  727 ±  14 
Lymph node cells  <15  <15  ND¶  <15  823 +  106  324 ±  85 
* Supernatants were obtained after incubation of the respective cell  populations for 24  h  and  added  at 
various concentrations (20-80%  vol/vol) to anti-/t-activated B cells  (5 X  10  ~ cells/well). 
:~ These two strains are of the lpr/lpr genotype. 
§ Numbers indicate IgSC per culture at optimal concentration of the respective supernatants. Background 
numbers of IgSC obtained with anti-/t alone have been subtracted. 
¶ Not determined. 
supernatants (see below) had no effect on Ig secretion. The response of MRL/1 B cells 
to MRL/1-SN did not differ significantly from that of B cells from other strains. 
This effect of MRL/1-SN was greatly enhanced by activating B cells from several 
strains with  anti-/~-coated Sepharose beads  (Fig.  2).  Removal of macrophages from 
the T  cell-depleted BALB/c target cell population  had  no significant  effect on the 
MRL/1-SN  activity (828  +  101  IgSC/culture  in T  cell-depleted populations vs. 873 
+  79 IgSC/culture  in T  cell- and macrophage-depleted populations). Therefore, no 
attempts were made to remove macrophages from the target population in subsequent 
experiments. As previously shown by others (19-21), anti-/.t by itself has little effect on 
Ig secretion. However, when T  cell-derived supernatants from the appropriate source, 
such as CAS, are added, then anti-/l-activated B cells are stimulated to secrete Ig. As 
can be seen  from Fig.  3,  both  MRL/I-SN and  CAS  caused  Ig secretion by anti-/l- 
treated B cells, whereas a  supernatant  from the TRF-producing line C.C3.11.75  had PRUD'HOMME  ET  AL.  735 
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Fro.  4.  Capacity of MRL/I-SN from mice of various ages to induce Ig secretion,  l0  b BALB/c B 
cells/culture were activated with anti-~. Results represent  IgSC/well zlz 1 SD assayed after 4 d of 
culture. Similar results were obtained with supernatants from lymph nodes. 
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Fro.  5.  MRL/l-derived lymphoid cell population responsible  for the production of Ig secretion- 
inducing factor(s).  Surface  lg  ÷ (B cells), T  cells, or Lyt-defined T  cell subsets were removed  by 
appropriate treatments (see Materials and Methods)  from spleen cells of 4-too-old MRL/I mice. 
Supernatants were  produced  from  the recovered  cells and tested  for  their ability to  induce Ig 
secretion in anti-#-activated BALB/c B cells (10  s cells/well). The results represent the mean of three 
experiments.  For each point, 1 SD represented  < 10% of the mean. 
no effect in this assay. In addition, both MRL/I-SN  and CAS enhanced Ig secretion 
of LPS-activated B  cells. Nevertheless, as shown later, there are significant differences 
between MRL/1-SN  and CAS. 
Association  of the  lpr/lpr  Genotype with  Production of a  BCDF.  Supernatants  were 
prepared  from  the spleen and  lymph  nodes  of adult  (>4  mo old)  MRL/Mp-+/+, 
BALB/c,  C57BL/6  (B6),  C3H,  and C57BL/6J-lpr/lpr  (B6/1)  mice. Of these strains, 
only  the  supernatants  derived  from  B6/1  mice  (spleens  or  lymph  nodes)  induced 
differentiation  of  anti-#-activated  B  cells  (Table  I).  The  B6/1  strain  develops  an 
autoimmune  and T  cell proliferative syndrome similar to that of the MRL/I  mouse, 736  B CELL  DIFFERENTIATION FACTOR IN lpr/lpr LUPUS  MICE 
except that the disease appears in the former when they are several months older (11). 
On the other hand, as noted above, supernatants from the MRL/Mp-+/+  (MRL/n) 
substrain, which is congenic with MRL/1 but lacks the lpr gene, were ineffective. We 
conclude that the lpr gene, regardless of the genetic background, is sufficient to induce 
the production of a  BCDF. 
Age  When  MRL/l-derived  L-BCDF Production  Begins.  Analysis of MRL/1-SN  from 
mice of different ages revealed that the production of L-BCDF began as early as 1 mo 
of age and therefore antedated morphologic evidence of lymphoproliferation (Fig. 4). 
Moreover, quantities of L-BCDF increased with age and roughly matched the degree 
of lymphoproliferation in older animals (2). 
Cell  Where  L-BCDF  Originates.  Because  the  mesenteric  lymph  nodes  of  old 
MRL/L  mice  consist  of >95%  T  cells  (3),  T  cells were  immediately suspected  of 
producing the factor. Accordingly, depletion of adherent cells and B cells by panning 
with anti-Ig-coated plates had no effect on L-BCDF production by spleen cells (Fig. 
5).  Conversely,  depletion  of  T  cells  from  spleen  cell  populations  by  combined 
treatment with monoclonal anti-Thy-1.2, anti-Lyt-1.2, and anti-Lyt-2.1 and C  almost 
completely abrogated L-BCDF production. Treatment  with anti-Lyt-l.2 and C  only 
partially abrogated L-BCDF production, presumably because many  MRL/1  T  cells 
express only a  low density of Lyt-l.2 antigen (3, 4). In contrast, treatment with anti- 
Lyt-2.1  and  C  had  no  effect  on  L-BCDF  production.  Apparently,  L-BCDF  was 
produced by a  Thy-1 +,  Lyt-l+2  -  cell, which  is the dominant  cell in MRL/I  lymph 
nodes. 
MRL/I-SN  Lacks  BCGF-Iike  Activity.  Although  B  cells proliferate in  response  to 
anti-~t in  high  cell density  (HCD)  cultures,  they  fail to  respond  to  low cell density 
(LCD)  cultures unless BCGF is added  (22).  We found  that  neither MRL/1-SN  nor 
CAS induced proliferation of B cells in LCD or HCD  cultures with anti-/x (Table II) 
or without  anti-~  (data not  shown).  Nevertheless,  MRL/1-SN  induced  Ig secretion 
very effectively in  LCD conditions, despite little or no  B  cell proliferation. Interest- 
ingly, CAS could induce Ig secretion only in HCD  cultures. 
Unlike CAS, MRL/l-SN Acts in the Absence of IL-2.  Using a  standard assay we could 
not detect IL-2 in MRL/1-SN (Table III), although it was clearly present in CAS. To 
eliminate the possibility that low levels of IL-2 were present in MRL/1-SN and might 
have influenced this supernatant's activity, we absorbed supernatants with  an IL-2- 
TABLE II 
Effect of Cell Density* on the Response of B Cells to MRL/l-SN vs. CAS from a Normal Mouse Strain 
Proliferation (SI)~  Differentiation  (SI):~ 
Treatment 
LCD  HCD  LCD  HCD 
Anti-/~  0.9 + 0.3  30.0 -¢- 4.7  1.9 +_ 0.3  2.2 ±  1.5 
Anti-/~ + MRL/1-SN§  1.1 + 0.3  28.6 -+ 4.1  99.5 +- 19.0  84.0 ±  10.4 
Anti-/~ + CAS§  0.9 ± 0.4  29.4 +- 4.2  2.1 +- 0.3  70.5 ± 9.2 
* Cell cultures were set up at LCD (5 x  104 cells/250 ~1), or HCD (5 ×  10  ~ cells/250 ~l). 
:~ Stimulation  index  (SI) =  experimental/medium control.  Proliferation  is  assayed by  [3H]thymidine 
uptake,  whereas differentiation  is measured by reverse hemolytic plaque assay. Results represent  the 
mean --+ t SD of three experiments. 
§ Results listed are at 40% (vol/vo|) supernatant  concentration.  Varying the concentration  of the super- 
natants (10-80%) had no significant effect on proliferation or on the differentiation  response to CAS in 
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TABLE  III 
IL-2 Dependency of CAS but Not MRL/I-SN  for Induction of B Cell Differentiation 
Differentiation (IgSC/  Supernatant*  CTLL absorption:~  IL-2 activity (SI)§  culture) 
Medium  -  1.0  10 
MRL/1-SN  -  1.2  820 
CAS  -  24.8  728 
MRL/I-SN  +  1.1  811 
CAS  +  1.4  15 
* MRL/I-SN (80% vol/vol) and CAS (80% vol/vol) were added to anti-/~-activated B cells (5 ×  100 cells/ 
culture). 
1 ml of supernatant was absorbed with 4 ×  106 cells of line CTLL-2-15-H for 24 h at 37°C. 
§ [SH]thymidine uptake of the CTLL line; SI =  counts per minute with supernatant divided by counts per 
minute with medium alone. The results of a representative experiment are shown. 
TABLE  IV 
MRL/I-SN Enhances Both IgM and IgG Production in LPS-activated B Cells 
Isotypes secreted 
Strain of origin  Superna-  Total  (percentage of total IgG)  IgG 1, 2a, 2b/ 
of B cells cul-  IgM 
tured with LPS*  tant~  IgG§  IgG3 ratio 
IgG3  igG~  IgG2b  IgG2a 
ng/ml  ng/ml 
--  230  33  50.1  6.1  25.0  18.8  1.0 
BALB/c  MRL/I-SN  603  227  6.6  18.5  49.3  25.6  14.1 
--  613  55  16.4  7.2  30.9  45.4  5.1 
MRL/I  MRL/I-SN  1211  560  2.8  16.1  27.5  53.6  34.7 
* Anti-Thy-l.2 plus C-treated spleen cells were cultured at a concentration of 5 ×  104 cells/well for 6 d in 
the presence of 2.5/~g/ml of LPS. 
:]: MRL/I-SN was added at 40% (vol/vol). 
§ Total IgG is the sum of the values obtained with the four IgG subclasses.  IgM and IgG subclasses were 
determined by radioimmunoassay. The results shown represent the mean of three experiments. In all 
cases, SD was <10% of the mean. 
TABLr  V 
Absence of Conventional TRF Activity in MRL/I-SN 
Supernatant*  PFC:~ 
Medium  3 ±  1 
CAS  150 ±  15 
MRL/1-SN  2 ±  1 
* CAS and MRL/1-SN were added at a concentration of 40% vol/vol. 
:~ Direct anti-SRBC PFC per 106 cultured cells ±  1 SD. 
dependent  cell  line.  This  absorption  had  no  effect  on  the  ability  of MRL/I-SN  to 
induce  differentiation  (Table  III).  In  marked  contrast,  IL-2  absorption  completely 
removed  the  ability of CAS  to  induce  B  cell  differentiation.  We  conclude  that  the 
differentiation factor present in MRL/I-SN  is distinct from that  in CAS. 
MRL/I-SN Enhances Both IgM and lgG Secretion in LPS-activated B  Cells.  B  cells were 
cultured  at  low cell  density in  the presence of LPS  for 6  d.  Although  LPS  by itself 
induced  both IgM  and  IgG secretion, we found  that both Ig classes were enhanced  by 
the addition  of MRL/I-SN  (Table  IV).  Furthermore,  IgG secretion was enhanced  to 
a  greater  extent  than  IgM  secretion.  LPS  by  itself induced  mostly  IgG3  and  IgG2b 738  B CELL DIFFERENTIATION FACTOR IN lpr/lpr LUPUS MICE 
secretion in BALB/c mice. The addition of MRL/I-SN with LPS had little effect on 
IgG3 secretion but considerably enhanced the production of IgG 1, IgG2a, and IgG2b. 
This can be seen as a  redistribution  in the isotype percentages accounting  for total 
IgG, and as a considerable increase in the IgG1, 2a, 2b/IgG3 ratio. It is noteworthy 
that MRL/I B ceils produced more IgG2a in response to LPS alone than did those 
from BALB/c mice. This may reflect in vivo exposure of MRL/1 B cells to L-BCDF, 
or may possibly be a primary property of MRL/I B cells. 
MRL/l-SN Lacks  TRF Activity.  MRL/1-SN could not reconstitute the primary in 
vitro response of B  cells to  SRBC,  whereas  CAS  gave a  positive result  (Table V). 
Thus, we could not demonstrate conventional TRF activity (23,  24)  in MRL/1-SN. 
Furthermore,  DL-TRF,  the  product  of a  cloned  T  cell  line  (25,  26),  which  can 
reconstitute  primary in  vitro responses to  SRBC,  could  not  induce  Ig secretion  by 
anti-~-activated B cells (Fig. 3). 
Discussion 
In this paper we document the in vitro production of an L-BCDF by unstimulated 
(i.e.,  in the absence of mitogens) lymph node and spleen cells of the MRL/I mouse. 
L-BCDF acts on unmanipulated  B cells; however, its effect is much greater on anti- 
/~- or LPS-activated B cells. It should be noted in this respect that unmanipulated  B 
cells may contain a small percentage of B ceils that had been activated in vivo or by 
antigens and mitogens present in the culture media. Because the response of unma- 
nipulated B cells was quite low, it may be that only activated B ceils are responding 
to the L-BCDF. The factor appears to act directly on B ceils and not  indirectly via 
macrophage products.  B cells from murine strains of three different H-2 haplotypes 
all responded  to L-BCDF, indicating no apparent  genetic restriction of this factor's 
activity. The animals' age when this factor appears precedes morphologic evidence of 
lymphoproliferation. However, the quantity of factor produced roughly matches the 
degree of lymphoproliferation in MRL/1 mice >2 mo old. Unstimulated lymphocytes 
of the  congenic  strain  MRL/n  (which  lacks  the  Ipr  gene)  did  not  induce  B  cell 
differentiation;  similarly, normal mouse strains did not produce a  detectable BCDF. 
On  the  other  hand,  mice of the C57BL/6-lpr/lpr  strain  produced  a  similar  factor, 
which suggests that the lpr gene is linked with both lymphoproliferation and L-BCDF 
production. 
Cell depletion studies performed with monoclonal antibodies and C or by panning 
reveal that the cell producing L-BCDF is a T cell of Lyt-1  +2- phenotype. Interestingly, 
this is the phenotype of the proliferating cell in MRL/I mice that accounts for >95% 
of all cells in MRL/1 lymph nodes (4). 
Early in the study of MRL/1-SN we found similarities between  this supernatant 
and CAS derived from normal mouse strains. Thus, both MRL/1-SN and CAS could 
induce Ig secretion in anti-/x- or LPS-activated B cells. It soon became clear, however, 
that there were major differences between MRL/1-SN and CAS. First, we found that 
CAS  could  only  induce  Ig secretion  in  anti-/x-activated  B  cells  in  HCD  cultures, 
whereas MRL/I-SN acted regardless of cell density.  Second,  the action of CAS was 
IL-2 dependent and could be completely abrogated by IL-2 absorption. On the other 
hand, MRL/I-SN did not contain detectable IL-2. The possibility that trace amounts 
of IL-2 were influencing the activity of MRL/I-SN was excluded by absorption with 
an  IL-2-dependent  line.  Thus,  L-BCDF  (from  MRL/1-SN)  appears  to  induce  Ig PRUD'HOMME  ET AL.  739 
secretion in the complete absence of IL-2. Recently, Parker (27)  reported on the IL-2 
dependency of CAS using a similar assay and suggested that in addition to IL-2, CAS 
contains a second factor (TRF) that induces B cell differentiation. Because our results 
demonstrate both an HCD requirement and an IL-2 requirement  for CAS activity, 
we believe that this supernatant can only induce Ig secretion if sufficient residual T 
cells  (there are fewer T  cells per well in  LCD cultures)  are present in culture.  This 
view is consistent with the results of T  depletion studies performed by others (28)  in 
the rat  model. On the other hand,  L-BCDF acts independently  of cell density and 
appears to exert its effect directly on the B cell without the need for an intermediary 
helper cell. 
MRL/I-SN had no effect on B cell proliferation in the presence or absence of anti- 
~, regardless of cell density. Because BCGF has been shown to increase the proliferation 
of anti-#-activated B cells in LCD cultures  (22), we conclude that there is no BCGF- 
like activity in MRL/1-SN. 
Although  it  is  clear  that  L-BCDF  is  a  factor distinct  from IL-2 and  BCGF,  its 
relationship to TRF is more difficult to define. At the present time, it is not clear that 
TRF, as assayed by different groups, represents one factor (23,  24, 26, 29, 30). Indeed, 
there  is no assay that  detects TRF  independent  of any other  factor.  In  the  classic 
assay, TRF restores the primary in vitro response to SRBC (23, 24). In this respect, L- 
BCDF has no TRF activity. However, TRF activity has been shown to depend on the 
joint action of IL-2, BCGF, TRF, and possibly IL-1 (22, 26, 31). Some authors claim 
that TRF can only induce B cell differentiation in collaboration with IL-2 (26, 27). In 
fact, we found that DL-TRF, the product of a cloned T  cell line (26), could not induce 
Ig secretion of antio#-activated B cells. Our results strongly suggest that L-BCDF is a 
factor distinct from TRF. Isakson et al. (32) have identified BCDF from cloned T  cell 
lines that induce IgM secretion (BCDF#)  or IgG secretion  (BCDFy) without having 
conventional  TRF activity. On the basis of their data and our own,  it would  seem 
that  there  exists  a  family of BCDF  that  includes  TRF  and  L-BCDF.  The  exact 
relationship  of these  BCDF evidently will  require  extensive studies  and  cannot  be 
resolved at this time. 
L-BCDF  enhanced  both  IgM  and  IgG  production  by  LPS-activated  B  cells. 
Interestingly, IgG production was more responsive to L-BCDF than IgM production. 
LPS by itself induced mostly IgG3 and IgG2b secretion in BALB/c mice, as previously 
reported  (33,  34).  The  addition  of L-BCDF  to  LPS-stimulated  cultures  had  little 
additional  effect on  IgG3 secretion,  but  caused a  marked increase in  IgG1, IgG2a, 
and  IgG2b secretion.  We have recently found  that  surface Ig- B  cells  (pre-B cells) 
respond in a similar fashion (unpublished observation), which suggests that L-BCDF 
may induce switching from IgM to IgG production. 
Analysis of serum immunoglobulins in SLE and especially in MRL/1 mice reveals 
that with aging there is a switching from IgM to IgG production (7, 35). Furthermore, 
in  the MRL/I  mice the predominant  isotypes produced  are IgG1  and  IgG2a.  2 We 
have also shown  3 that MRL/I mice produce a greater percentage of IgG2a and IgG2b 
in response to T-independent type 1 and T-dependent antigens when compared with 
Berden, J. H. M., L. M. Hang, P. J. McConahey, and F. J. Dixon. 1982. Analysis of vascular lesions 
in murine SLE. I. Association with serological  abnormalities.J. ImmunoL In press. 
a Park, C. L., R. S. Balderas, T. Fieser, G.J. Prud'homme, F. J. Dixon, and A. N. Theofilopoulos. 1982. 
Isotypic profiles and other fine characteristics of immune responses of SLE mice to exogenous TD- and TI- 
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normal mice. Interestingly, MRL/I mice are highly prone to develop serum mono- 
clonal gammopathies (36).  The random analysis of 11 serum monoclonal peaks from 
MRL/I mice in our laboratory revealed that 5 were of the IgG2a subclass, 5 were of 
the IgG1 subclass, and  1 was of the IgG2b subclass, but  none was of IgM or IgG3 
isotype.  4 These results provide in vivo analogies for the in vitro effect of L-BCDF on 
B cells. 
Recently,  4 we have investigated other SLE mouse strains (BXSB, NZB, NZB/NZW 
F1)  for the  production  of lymphoid cell-derived factors that  affect B  cell  function. 
Preliminary  evidence  suggests  that  such  factors  are  present  in  other  autoimmune 
strains  at  a  time that  antedates  or coincides with  the  appearance of overt disease. 
Thus, we have evidence that autoimmune mice of genetic backgrounds different from 
MRL/1  and  lacking  T  cell  proliferation  also  spontaneously  produce  factors  that 
stimulate B cell function. Further studies will be necessary to determine whether these 
factors are related to L-BCDF.  It is noteworthy  that  in  all murine  SLE strains we 
have studied the rise in production of B cell differentiation factor(s) is accompanied 
by a concomitant decrease in IL-2 production. This association may not be accidental. 
Indeed,  it  has been suggested  (9-11)  that  IL-2 may act  on  regulatory T  cells  that 
prevent or delay the appearance of autoantibody production in murine SLE. Possibly, 
defective IL-2 production is a necessary prerequisite for increased BCDF production. 
This question is of more than theoretical interest because not only murine SLE, but 
also human SLE is characterized by a decrease in IL-2 production  (37). 
Summary 
Lymph node and spleen cells of the autoimmune MRL/Mp-lpr/lpr  mouse strain 
spontaneously  produce  (in  the  absence  of mitogenic  stimulation)  a  factor(s)  that 
induces B  cell differentiation.  This factor is not produced  by the congenic MRL/n 
mouse strain that lacks the lpr gene or by normal mouse strains. However, lymphoid 
cells  of  the  B6-lpr/lpr  (B6/I)  strain  also  produce  a  B  cell  differentiation  factor. 
Although the factor acts on resting B cells, its effect is greatly magnified by activating 
the B cells with anti-/~ or lipopolysaccharide. MRL/I mice begin producing the factor 
as early as  1 mo of age but  levels increase with age and appearance of lymphopro- 
liferation. Cell depletion studies reveal that this factor is produced by T  cells of the 
Lyt-l+2  -  phenotype. Because of its association with the lpr/lpr genotype, we term this 
B cell differentiation factor L-BCDF. Functional analysis of L-BCDF reveals that it 
acts regardless of cell density in culture and in the absence of interleukin 2 (IL-2). In 
fact, the increase in the production of L-BCDF by MRL/I T  cells with aging occurs 
concomitantly with  a  marked decrease  in  their  ability to  produce  IL-2.  No T  cell 
replacing  factor  activity  or  B  cell  growth  factor-like  activity  can  be  detected  in 
MRL/1-derived  supernatants.  L-BCDF  induces  both  IgM  and  IgG  synthesis  in 
lipopolysaccharide-activated B cells; however, it has a greater effect on IgG secretion. 
In particular, the production of IgG1, IgG2a, and IgG2b are markedly enhanced  in 
the presence of L-BCDF. The spontaneous production of L-BCDF by T  cells of SLE 
mice of lpr/lpr genotype suggests an association of this factor with autoimmunity. 
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